Table 2.

Medication profile

Group	Non Hallucinators	Hallucinators
	N = 39	N = 31
L-dopa	38 (97.4%)	30 (96.8%)
Dopamine Agonist	25 (64.1%)	18 (58.1%)
Amantadine	9 (23.1%)	7 (22.6%)
Anticholinergics	4 (10.3%)	4 (12.9%)
COMT inhibitors	7 (17.9%)	4 (12.9%)
MAO-B inhibitors	2 (5.1%)	3 (9.7%)
Cholinesterase inhibitors	4 (10.3%)	1 (3.2%)
Antipsychotics*	0	5 (16.1%)
Antidepressants	12 (30.8%)	11 (35.5%)

*p = 0.01